Current Price - $3.73
Sector: Health Technology
Industry: Medical Specialties
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. The ArgusCYTE Breast Health Test offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
MAC's Hot Stock is $ATOS - After being added to the Russell 2000 this company shot up to $9.00 a share, there is some news bubbling about some nonsense that doesn't matter, if interested here is the headline and link to article -(SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Atossa Therapeutics, Inc. - ATOS - Link Here) - MAC is not a FUD'er and is completely agnostic and impartial when it comes to picking stocks because markets are unpredictable! This could shoot up to $9 again after bouncing around it's lows for a couple months after it's initial pop. MAC is buying calls and selling puts also holding shares.
MAC is setting buys at $3.66 and setting limit orders in the conservative $5.00 range.
THIS IS NOT TRADING ADVICE - MAC IS NOT A PROFESSIONAL STOCK TRADER ALL INFORMATION IS PUBLIC KNOWLEDGE AND COMMON SENSE.